Aurobindo Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

10,645.64

12,792.28

11,287.14

15,823.68

13,266.48

Operating profit

2,224.04

1,730.92

1,473.40

4,119.82

2,685.75

Interest

182.60

114.98

16.94

28.68

95.58

Gross profit

2,657.50

2,049.70

2,127.45

4,681.00

2,848.18

EPS (Rs)

33.35

21.00

24.83

53.13

31.96

Other income

616.06

433.76

670.99

589.86

258.01

Stock adjustment

-116.23

-466.00

45.51

2.99

-229.53

Raw material

5,761.08

7,247.69

5,783.93

7,215.73

6,747.55

Power and fuel

-

-

-

-

-

Employee expenses

980.56

1,641.88

1,600.04

1,735.43

1,561.47

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1,796.19

2,637.79

2,384.26

2,749.71

2,501.24

Provisions made

-

-

-

-

-

Depreciation

254.58

435.35

415.26

487.99

470.48

Taxation

502.82

383.94

182.77

1,080.10

504.96

Net profit / loss

1,954.14

1,230.41

1,454.71

3,112.91

1,872.74

Extra ordinary item

54.04

-

-74.71

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

58.59

58.59

58.59

58.59

58.59

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

20.89

13.53

13.05

26.04

20.24

GPM (%)

23.60

15.50

17.79

28.52

21.06

NPM (%)

17.35

9.30

12.17

18.97

13.85